| Financial Year |
March 31 2023 |
| Monetary Funds |
191,808,825.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,415,000.00 |
| Accounts Receivable |
391,038,702.25 |
| Advances to Suppliers |
79,593,156.74 |
| Other Receivables |
41,247,732.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
271,457,648.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,824,189.78 |
| Total Current Assets |
1,271,016,584.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
116,975,320.45 |
| Investment Properties |
4,195,912.55 |
| Fixed Assetes |
274,762,140.41 |
| Under-construction Projects |
25,965,161.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,986,321.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,357,814.59 |
| Deferred Income Tax Assets |
23,321,690.53 |
| Other Non-Current Assets |
15,865,684.26 |
| Sub-Total of Non-Current Assets |
536,432,271.87 |
| Total Assets |
1,807,448,856.45 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,790,960.97 |
| Accounts Payable |
243,650,212.43 |
| Accounts Received In Advance |
12,557.32 |
| Employee Compensation Payable |
-- |
| Taxes Payable |
318,845.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,884,039.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,000.00 |
| Other Current Liabilities |
13,697,218.10 |
| Sub-Total of Current Liabilities |
513,350,101.60 |
| Long-term Loans |
7,009,041.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
110,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,537,697.16 |
| Other Non-Current Liabilities |
19,037,115.30 |
| Sub-Total of Non-Current Liabilities |
84,190,495.50 |
| Total Liabilities |
597,540,597.10 |
| Paid-In Capital(Or Share Stock) |
122,642,024.00 |
| Capital Surplus |
521,601,363.94 |
| Surplus Reserve |
55,982,068.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
509,407,386.88 |
| Minority Stockholder's Interest |
275,416.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,209,632,843.30 |
| Owner's Equity（Stockholder's Equity） |
1,209,908,259.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,807,448,856.45 |
